# Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older

> **NCT02677636** · PHASE3 · WITHDRAWN · sponsor: **Merz North America, Inc.**

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** MSRD-100
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT02677636
- **Lead sponsor:** Merz North America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2016-07
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02677636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02677636, "Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02677636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*